These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1742721)

  • 21. Familial obsessive-compulsive disorder presenting as pathological jealousy successfully treated with fluoxetine.
    Wright S
    Arch Gen Psychiatry; 1994 May; 51(5):430-1. PubMed ID: 8179468
    [No Abstract]   [Full Text] [Related]  

  • 22. Continuation treatment of OCD: double-blind and open-label experience with fluoxetine.
    Tollefson GD; Birkett M; Koran L; Genduso L
    J Clin Psychiatry; 1994 Oct; 55 Suppl():69-76; discussion 77-8. PubMed ID: 7961535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluoxetine-induced akathisia in male OCD patients.
    Friedman EH
    J Clin Psychiatry; 1990 May; 51(5):212. PubMed ID: 2378629
    [No Abstract]   [Full Text] [Related]  

  • 24. Antidepressant-induced mania in obsessive-compulsive disorder.
    Vieta E; Bernardo M
    Am J Psychiatry; 1992 Sep; 149(9):1282-3. PubMed ID: 1503154
    [No Abstract]   [Full Text] [Related]  

  • 25. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.
    Riddle MA; Scahill L; King RA; Hardin MT; Anderson GM; Ort SI; Smith JC; Leckman JF; Cohen DJ
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1062-9. PubMed ID: 1429406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obsessive-compulsive disorder in HIV disease. Response to fluoxetine.
    McDaniel JS; Johnson KM
    Psychosomatics; 1995; 36(2):147-50. PubMed ID: 7724717
    [No Abstract]   [Full Text] [Related]  

  • 27. Manic behaviors associated with fluoxetine in three 12- to 18-year-olds with obsessive-compulsive disorder.
    Go FS; Malley EE; Birmaher B; Rosenberg DR
    J Child Adolesc Psychopharmacol; 1998; 8(1):73-80. PubMed ID: 9639082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoxetine and memory impairment.
    Friedman EH
    J Am Acad Child Adolesc Psychiatry; 1994 Jun; 33(5):763. PubMed ID: 8056743
    [No Abstract]   [Full Text] [Related]  

  • 29. Open trial of fluoxetine in obsessive-compulsive disorder.
    Jenike MA; Buttolph L; Baer L; Ricciardi J; Holland A
    Am J Psychiatry; 1989 Jul; 146(7):909-11. PubMed ID: 2787123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and fluoxetine treatment of compulsive behavior disorder of adults with mental retardation.
    Bodfish JW; Madison JT
    Am J Ment Retard; 1993 Nov; 98(3):360-7. PubMed ID: 8292312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful fluoxetine treatment of pathologic jealousy.
    Lane RD
    J Clin Psychiatry; 1990 Aug; 51(8):345-6. PubMed ID: 2380161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluoxetine and bleeding in obsessive-compulsive disorder.
    Yaryura-Tobias JA; Kirschen H; Ninan P; Mosberg HJ
    Am J Psychiatry; 1991 Jul; 148(7):949. PubMed ID: 2053641
    [No Abstract]   [Full Text] [Related]  

  • 33. Toxic reaction following the combined administration of fluoxetine and L-tryptophan: five case reports.
    Steiner W; Fontaine R
    Biol Psychiatry; 1986 Sep; 21(11):1067-71. PubMed ID: 3488767
    [No Abstract]   [Full Text] [Related]  

  • 34. Fluoxetine treatment of obsessive-compulsive disorder.
    Turner SM; Jacob RG; Beidel DC; Himmelhoch J
    J Clin Psychopharmacol; 1985 Aug; 5(4):207-12. PubMed ID: 3894437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible interaction between fluoxetine and pimozide causing sinus bradycardia.
    Ahmed I; Dagincourt PG; Miller LG; Shader RI
    Can J Psychiatry; 1993 Feb; 38(1):62-3. PubMed ID: 8448725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
    Etain B; Bonnet-Perrin E
    Encephale; 2001; 27(3):280-9. PubMed ID: 11488259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of long-term fluoxetine treatment of obsessive-compulsive disorder.
    Frenkel A; Rosenthal J; Nezu A; Winston A
    Mt Sinai J Med; 1990 Nov; 57(6):348-52. PubMed ID: 2079952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Body dysmorphic disorder.
    Albertini RS; Phillips KA; Guevremont D
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1425-6. PubMed ID: 8936908
    [No Abstract]   [Full Text] [Related]  

  • 39. Buspirone augmentation of fluoxetine in obsessive-compulsive disorder.
    Markovitz PJ; Stagno SJ; Calabrese JR
    Am J Psychiatry; 1990 Jun; 147(6):798-800. PubMed ID: 2188516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment.
    King RA; Riddle MA; Chappell PB; Hardin MT; Anderson GM; Lombroso P; Scahill L
    J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):179-86. PubMed ID: 2016219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.